Multivariate analysis of prognostic factors for overall survival and progression-free survival
| Variables | Risk factors | HR (95% CI) | P values |
| Overall survival | |||
| Pathology | Non-endometrioid vs endometrioid | 2.10 (0.97 to 4.59) | 0.06 |
| Grade | III vs I and II | 2.31 (1.11 to 4.79) | 0.03 |
| Myometrial invasion | ≥50% vs<50% | 2.35 (1.02 to 5.43) | 0.04 |
| No of PA ln metastasis | 1 vs. >1 | 1.05 (0.58 to 1.90) | 0.7 |
| Adjuvant treatment | RT vs RT and ChT | 4.68 (2.50 to 8.78) | <0.001 |
| Progression-free survival | |||
| Pathology | Non-endometrioid vs endometrioid | 2.11 (0.97 to 4.59) | 0.06 |
| Grade | III vs I and II | 2.23 (1.12 to 4.65) | 0.02 |
| Myometrial invasion | ≥50% vs<50% | 2.31 (1.02 to 5.22) | 0.04 |
| Adjuvant treatment | RT vs RT and ChT | 4.67 (2.49 to 8.76) | <0.001 |
ChT, chemotherapy; PA, paraaortic; RT, radiotherapy.